Published Date: 17 Feb 2023
United States: Research has shown that dual-energy X-ray absorptiometry (DXA) scans can be used to diagnose CF-related bone disease in children...
Read Full NewsThe AAN's new guideline enhances diagnosis and management of functional seizures, emphasizing psychological interventions and addressing care gaps for better patient outcomes.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 30, 2026.
Mallon explains the shared risks linking celiac disease and type 1 diabetes and why early screening improves outcomes.
Nedelkopoulou emphasizes the importance of structured and multidisciplinary transition programs for young patients with IBD and HPB disease.
FDA Accepts Oxylanthanum Carbonate NDA Resubmission for Hyperphosphatemia in CKD, Dialysis
6 Nephrology Headlines You Missed In January 2026
OptIMMize-1: New Efficacy and Safety Data on Risankizumab in Pediatric Psoriasis
1.
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer
2.
Both men and women who receive the HPV vaccine have a lower risk of developing multiple cancer types.
3.
Dementia-like protein buildup found in pancreas cells before cancer develops
4.
a cutting-edge cancer diagnostic tool.
5.
'Ray of hope': New developments in the fight against various cancers.
1.
What are Acanthocytes? Understanding the Role of Spiky Red Blood Cells
2.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
3.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
4.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
5.
Understanding Neutropenic Fever: What It Is and Why it's a Serious Concern
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
2.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
3.
Navigating the Complexities of Ph Negative ALL - Part IX
4.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation